| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 49 | 19.4x | 17.8x | Around median | |
Growth | 71 | 3.0% | 7.1% | Top tier | |
Quality | 93 | — | — | Top tier | |
Safety | 31 | — | — | Bottom tier | |
Capital Return | 47 | 1.19% | 2.12% | Around median | |
Momentum | 66 | 3.2% | 2.9% | Around median | |
Sentiment | 47 | 14 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Willis Towers Watson Public Limited Company (WTW) operates in consulting, risk management, insurance brokerage, and human capital and benefits solutions. It generates revenue through two main segments: Health, Wealth & Career, which provides health, retirement, rewards, and benefits administration solutions, and Risk & Broking, which combines specialized risk brokerage with insurance consulting and technology. The company supports its model through long-term consulting relationships, recurring administration and service contracts, specialized projects, software sales, and multi-year technology agreements.
In Q2 fiscal 2026, EDGAR data showed revenue of $2.5 billion, net income of $229 million, and earnings per share of $2.43. On the adjusted basis presented by management, revenue was $2.47 billion, organic revenue grew 5%, adjusted operating margin was 19.5% after expanding 100 basis points, and adjusted diluted earnings per share were $3.35, up 17% from the comparable period. By comparison, the company recorded revenue of $9.7 billion, net income of $1.6 billion, and earnings per share of $16.26 in fiscal 2025.
Risk & Broking led performance in Q2 fiscal 2026 with organic growth of 7% and an operating margin of 22.2%, up 100 basis points, while Health, Wealth & Career grew organically by 4% and achieved a margin of 24.1%, up 30 basis points. Within Health, Wealth & Career, Health grew 8% and Wealth grew 2%, while Career was flat and Benefits Delivery & Outsourcing grew 1%. Acquisitions contributed approximately three percentage points to reported revenue growth for the company overall and for each segment.
The analyst consensus is "Buy," with an average price target of $356.64 and a wide range between $300 and $406. The average target is only approximately 1.1% above the 52-week range high of $352.79, while the range low is $240.61; therefore, the valuation rationale largely depends on achieving the adjusted operating margin target of approximately 30% in 2028 and maintaining mid-single-digit organic growth. The available data do not provide a published price-to-earnings ratio that can be used as an additional valuation anchor, while the broad range of analyst targets highlights differing assessments of Propel execution risks, pressure in Career, and insurance pricing.
Figures in the text are as of 2026-08-28; the live price is shown at the top of the page.
WTW achieved organic growth of 5% and an adjusted operating margin of 19.5%, up 100 basis points from the comparable period. Adjusted diluted earnings per share were $3.35, up 17%, while EDGAR data showed net income of $229 million and revenue of $2.5 billion. Risk & Broking led growth at 7%, while Health, Wealth & Career grew 4%.
WTW announced on July 30, 2026, that Propel is a plan to accelerate the use of artificial intelligence and automation, and it is scheduled for completion by the end of 2028. The plan targets $400 million in annual savings at a cash cost of approximately $625 million, with $50 million reinvested and the company retaining net savings of $350 million. Management links the plan to reaching an adjusted operating margin of approximately 30% for the company, 35% for Health, Wealth & Career, and 30% for Risk & Broking in 2028.
WTW uses the Neuron platform and Willis Navigator to automate brokerage work, reducing the preparation of insurance schedules from four hours to approximately five minutes, while some property premium allocations that previously took two to four weeks are now completed within minutes. In benefits services, Violet Suite has more than 20 artificial intelligence capabilities in production, has served more than 12 million participants, and reduced their follow-ups by 60%. Rewards AI reached more than 5,000 client users, while the company launched AI Workforce Transformation in June 2026 using WorkVue, ChangeView, and its proprietary data.
Automated analysis for informational purposes only — not investment advice.
Risk & Broking was the fastest-growing segment in Q2 fiscal 2026, with organic growth of 7% and an operating margin of 22.2%. Within Health, Wealth & Career, Health led with organic growth of 8%, compared with 2% in Wealth, zero in Career, and 1% in Benefits Delivery & Outsourcing. Insurance Consulting and Technology also grew 6%, driven by software sales and new multi-year technology deals.
Career project work in the Middle East declined by approximately 50%, contributing to the unit's revenue remaining flat during Q2 fiscal 2026. In Risk & Broking, insurance rates declined across most lines except U.S. casualty and certain specialties, keeping the pricing environment competitive. Propel also requires approximately $625 million in spending, with most of the cost concentrated in 2027 and 2028, and achieving $350 million in net annual savings depends on the plan's actual execution.
The company repurchased $450 million of shares during Q2 fiscal 2026. It also paid quarterly cash dividends totaling $90 million, equivalent to $0.96 per share. On July 30, 2026, management reaffirmed its expectation of repurchasing at least $1 billion of shares during fiscal 2026, subject to market conditions, organic investment opportunities, and acquisitions.
